Levothyroxine Treatment in Pregnant Women with Thyrotropin Levels Ranging Between 2.5 and 10 mIU/L: A Propensity Score Matched Analysis

医学 左旋甲状腺素 怀孕 倾向得分匹配 置信区间 内科学 甲状腺过氧化物酶 优势比 回顾性队列研究 产科 甲状腺 遗传学 生物
作者
Shen Gao,Xueran Wang,Rong Zhao,Yuchen Cui,Shaofei Su,Enjie Zhang,Jianhui Liu,Shuanghua Xie,Yue Zhang,Yuxi Yang,Kaikun Huang,Minhui Hu,Wentao Yue,Ruixia Liu,Chenghong Yin
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:34 (7): 912-919 被引量:1
标识
DOI:10.1089/thy.2023.0662
摘要

OBJECTIVE: To clarify the association between levothyroxine (LT-4) treatment and various adverse pregnancy outcomes in pregnant women with thyroid stimulating hormone (TSH) levels ranging between 2.5 to 10.0 mIU/L in the first trimester, stratified according to thyroid peroxidase antibody (TPOAb) positivity and TSH level. METHODS: This retrospective analysis of retrospectively and prospectively collected cohort data included Chinese pregnant women with TSH levels of 2.5–10 mIU/L and normal free thyroxine levels (11.8–18.4 pmol/L) in the first trimester. All participants were followed up until the completion of pregnancy, and information on LT-4 treatment, pregnancy complications, and pregnancy outcomes was recorded. A 1:1 nearest-neighbor propensity score matching (PSM) between the LT-4-treated and -untreated groups with a caliper distance of 0.02 was performed using a multivariable logistic regression model. Multivariable-adjusted modified Poisson regression was used to estimate the relative risk (RR) and 95% confidence interval (CI) of LT-4 treatment for adverse pregnancy outcomes. Subgroup analyses were also performed in four subgroups simultaneously stratified by TPOAb status (negative or positive) and TSH levels (2.5–4.0 mIU/L as high-normal group and 4.0–10.0 mIU/L as SCH group). The study was registered in the Chinese Clinical Trial Registry (ChiCTR2100047394). RESULTS: Among the 4,370 pregnant women in the study, 1,342 received LT-4 treatment, and 3,028 did not. The 1:1 PSM yielded 668 pairs of individuals and revealed that LT-4 treatment was significantly associated with a decreased risk of pregnancy loss (RR=0.528, 95% CI: 0.344–0.812) and an increased risk of small-for-gestational-age infants (RR=1.595, 95% CI: 1.023–2.485). Subgroup analyses suggested that the above effects of LT-4 treatment were mainly from TPOAb-negative participants. LT-4 treatment was associated with an increased risk of preterm birth (RR=2.214, 95% CI: 1.016–4.825) in TPOAb-positive pregnant women with high-normal TSH levels. CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5–4.0 mIU/L.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kangkirk发布了新的文献求助10
刚刚
刚刚
1秒前
1秒前
唠嗑在呐完成签到,获得积分20
2秒前
yyyyzz完成签到,获得积分10
3秒前
科目三应助hxm采纳,获得10
3秒前
4秒前
艺玲发布了新的文献求助10
5秒前
panda_123发布了新的文献求助20
5秒前
柠檬加盐完成签到,获得积分10
5秒前
6秒前
kangkirk完成签到,获得积分10
6秒前
乐乐应助古月采纳,获得10
7秒前
7秒前
芒果爸爸完成签到,获得积分10
8秒前
852应助一一采纳,获得10
8秒前
8秒前
nobody发布了新的文献求助10
8秒前
SherWei发布了新的文献求助10
9秒前
9秒前
10秒前
天天快乐应助GoodEnough采纳,获得10
10秒前
完美世界应助哭泣乌采纳,获得10
11秒前
艳艳完成签到,获得积分20
11秒前
12秒前
NexusExplorer应助Hexagram采纳,获得10
12秒前
思源应助木棉采纳,获得10
12秒前
12秒前
顾矜应助xiaoX12138采纳,获得10
13秒前
13秒前
11发布了新的文献求助20
14秒前
14秒前
14秒前
15秒前
量子星尘发布了新的文献求助10
15秒前
orixero应助带你去喝雪碧采纳,获得30
15秒前
an完成签到,获得积分10
16秒前
完美世界应助科研通管家采纳,获得10
16秒前
16秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976058
求助须知:如何正确求助?哪些是违规求助? 3520294
关于积分的说明 11202245
捐赠科研通 3256804
什么是DOI,文献DOI怎么找? 1798471
邀请新用户注册赠送积分活动 877610
科研通“疑难数据库(出版商)”最低求助积分说明 806496